Shenyang Xingqi Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 671.17 million compared to CNY 599.19 million a year ago. Revenue was CNY 685.47 million compared to CNY 600.57 million a year ago.

Net income was CNY 87.75 million compared to CNY 120.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.7071 compared to CNY 0.9786 a year ago. Diluted earnings per share from continuing operations was CNY 0.7071 compared to CNY 0.9786 a year ago.